Form 4 for UTI UNIVERSAL TECHNICAL INSTITUTE INC
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001261654-23-000147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | UTI | Grant Jerome Alan | CEO, Dir | F - Tax | $10.94 | -23.9K | 204.4K | -10% | -$261.8K |
| D | 2023-12-18 | 2023-12-14 | UTI | Grant Jerome Alan | CEO, Dir | M - OptEx | $0.00 | +57.9K | 228.4K | +34% | $0 |
| D | 2023-12-18 | 2023-12-14 | UTI | Grant Jerome Alan | CEO, Dir | M - OptEx | $0.00 | -57.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2023-12-14 | F | D | 23,932 | $10.94 | 204,443 | D | — | — | (F1) Vesting of Performance Units granted on 12/10/2020. Shares withheld to satisfy tax liability. |
| 2 | Common | Common Stock, $0.0001 par value | 2023-12-14 | M | A | 57,875 | $0.00 | 228,375 | D | — | — | |
| 3 | Derivative | Performance Units | 2023-12-14 | M | D | 57,875 | $0.00 | 0 | D | — · — to 2020-12-05 | 57,875 Common Stock, $0.0001 par value | (F2) Each performance unit represents a contingent right to receive one share of the Company's Common Stock, $0.0001 par value, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares. |